Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2910)
All Articles published online
|
Publishing Process of This Article
|
Aug 27, 2022 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vij M, Rammohan A, Rela M. Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection. World J Hepatol 2022; 14(8): 1541-1549 [PMID: 36157865 DOI: 10.4254/wjh.v14.i8.1541] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i8/1541.htm |
| Number | Citing Articles |
| 1 |
Hanlin L. Wang. Asymptomatic Allograft Fibrosis in Pediatric Liver Transplantation: Potential Clinical Implications. Transplantation 2023; 107(11): 2314 doi: 10.1097/TP.0000000000004604
|
| 2 |
Mebrahtu G. Tedla, Mebrihit M Kahsay, Mebrahtu G. Kidanu. Maintaining the optimum level of immunosuppressive agents minimizes risk of liver allograft fibrosis during Pediatric liver transplantation. International Journal of Surgery 2024; doi: 10.1097/JS9.0000000000000759
|
| 3 |
Shilpa Chawla, Subholakshmi Choudhury, Amitava Das. Bioengineered MSCGFPCxcr2-Mmp13 Transplantation Alleviates Hepatic Fibrosis by Regulating Mammalian Target of Rapamycin Signaling. Antioxidants & Redox Signaling 2024; 41(1-3): 110 doi: 10.1089/ars.2023.0390
|
| 4 |
Samuele Iesari, Francesca Laura Nava, Ilaria Elena Zais, Laurent Coubeau, Mariano Ferraresso, Evaldo Favi, Jan Lerut. Advancing immunosuppression in liver transplantation: A narrative review. Hepatobiliary & Pancreatic Diseases International 2024; 23(5): 441 doi: 10.1016/j.hbpd.2024.03.001
|
| 5 |
Toshiaki Nakano, Shigeru Goto, Chao-Long Chen. Mechanisms of Tolerance Induction in Liver Transplantation: Lessons Learned from Fetomaternal Tolerance, Autoimmunity and Tumor Immunity. International Journal of Molecular Sciences 2024; 25(17): 9331 doi: 10.3390/ijms25179331
|
| 6 |
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantation. Portal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
|
| 7 |
Madhumitha Rabindranath, Rita Zaya, Khairunnadiya Prayitno, Ani Orchanian-Cheff, Keyur Patel, Elmar Jaeckel, Mamatha Bhat. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis. Transplantation Direct 2023; 9(11): e1547 doi: 10.1097/TXD.0000000000001547
|
| 8 |
S. E. Voskanyan, V. E. Syutkin, A. I. Sushkov, Yu. V. Voskanyan, A. Yu. Veselkova. Liver allograft pathology in the late post-transplant period. Transplantologiya. The Russian Journal of Transplantation 2023; 15(3): 359 doi: 10.23873/2074-0506-2023-15-3-359-375
|
| 9 |
Nourhan Badwei. Hepatic allograft rejection after liver transplantation: Clinicopathological debates!. iLIVER 2023; 2(2): 116 doi: 10.1016/j.iliver.2023.05.003
|